|1.||Te, Alexis E: 2 articles (11/2006 - 06/2002)|
|2.||Altarac, Silvio: 2 articles (07/2006 - 11/2005)|
|3.||Wang, Hsin-Hsiao S: 1 article (12/2015)|
|4.||Zapata, Daniel: 1 article (12/2015)|
|5.||Wiener, John S: 1 article (12/2015)|
|6.||Routh, Jonathan C: 1 article (12/2015)|
|7.||Lipkin, Michael E: 1 article (12/2015)|
|8.||Velázquez, Nermarie: 1 article (12/2015)|
|9.||Taraphder, Abhijit: 1 article (09/2014)|
|10.||Mokhtari, Gholamreza: 1 article (01/2014)|
|1.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/01/2008 - "A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia."
10/01/2000 - "Medical therapy for benign prostatic hyperplasia is widely used but studies on only 2 alpha adrenergic blocking agents out the 5 pharmacological preparations currently in the field were reported. "
06/01/2008 - "Alpha-adrenergic blockers are an established form of medical treatment for symptomatic benign prostatic hyperplasia (BPH). "
11/01/2006 - "The application of oral medical treatments of lower urinary tract symptoms attributed to benign prostatic hyperplasia has traditionally utilized alpha-adrenergic blockers and 5alpha-reductase inhibitors. "
08/01/1990 - "Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia."
08/01/1990 - "Consequently, the long-term administration of alpha-adrenergic blocking agents in human heart failure has not been accompanied by an improvement in clinical status, exercise capacity, or survival.(ABSTRACT TRUNCATED AT 250 WORDS)"
09/01/2006 - "Adrenergic alpha blockers have been associated with an increased rate of heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and Vasodilator-Heart Failure Trial (V-HeFT). "
03/01/2004 - "Given the multifactorial etiology of benign hyperplasia, the usefulness of 5alpha-reductase inhibitors in combination with alpha adrenergic blockers has also been investigated and justified in select patients. "
01/01/2000 - "Alpha adrenergic blockers in the treatment of benign hyperplasia of the prostate."
04/01/1992 - " Benign prostate hyperplasia previously manageable only by surgery can respond favorably to 5 alpha-reductase inhibitors and/or selective alpha-adrenergic blockers in some patients according to recent data."
01/01/2014 - "Recent studies have shown the benefits of alpha-adrenergic blockers in preventing post-operative urinary retention (POUR). "
07/01/2006 - "[Alpha-adrenergic blockers as a support in the treatment of acute urinary retention]."
05/01/1988 - "Prevention and treatment of urinary retention and infection after surgical treatment of the colon and rectum with alpha adrenergic blockers."
06/01/2002 - "A search of literature published from 1966 to 2002 was performed on MEDLINE using the search terms phenoxybenzamine, alpha-adrenergic blockers, benign prostatic hyperplasia, neurogenic bladder, urinary retention, and complex regional pain Despite concerns about possible carcinogenicity, no reports of drug-related tumors have been made since PBZ's introduction in 1953. "
03/01/1988 - "Regarding potential treatments of spinal morphine-induced urinary retention, the present study suggests that: 1) cholinomimetic and alpha-adrenergic agonist agents might be harmful; 2) beta-adrenergic agonist and alpha-adrenergic blocking agents might be useful; and 3) dopaminergic agonist agents might be the drugs of choice."
|1.||5-alpha Reductase Inhibitors
|2.||Adrenergic alpha-Agonists (Adrenergic alpha-Agonist)
|3.||Dopamine Agonists (Dopamine Agonist)
|4.||Morphine (MS Contin)
|5.||Adrenergic beta-Agonists (beta-Adrenergic Agonists)
|6.||Calcium Channel Blockers (Blockers, Calcium Channel)
|7.||Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
|1.||Induced Hyperthermia (Thermotherapy)
|4.||Phytotherapy (Herbal Therapy)